Chandra B Tripathy1, Nilanjan Roy. 1. Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Sector 67, S. A. S. Nagar, Punjab 160062, India.
Abstract
BACKGROUND: We sought to evaluate the estimated risk of GSTM1 null genotype and squamous cell carcinoma of the head and neck (SCCHN). METHODS: The studies done so far for GSTM1 null genotype as a risk factor associated with head and neck cancer are not conclusive and have shown conflicting results. A meta-analysis has been carried out on 22 case-control studies collected from the literature. Precision of the risk estimate and presence of publication bias in those studies are also evaluated by funnel plot analysis. RESULTS: A total of 3527 cases and 4211 controls constitute the subjects of meta-analysis. The principal outcome measured was the odds ratio (OR) for the risk of head and neck cancer. Pooling the studies together, the OR was 1.50 (95% confidence interval [CI], 1.21-1.87). When stratified according to Asians and Caucasians, the OR increased in the Asians (OR, 1.93; 95% CI, 1.29-2.90), suggesting that the risk is more pronounced in Asians. However, a substantial amount of publication bias is also associated with studies conducted on the Asian population. CONCLUSION: A review of the 22 case-control studies for risk of SCCHN and GSTM1 null genotype indicate that greater attention should be paid to designing future studies so that a more precise risk estimate can be achieved. (c) 2005 Wiley Periodicals, Inc.
BACKGROUND: We sought to evaluate the estimated risk of GSTM1 null genotype and squamous cell carcinoma of the head and neck (SCCHN). METHODS: The studies done so far for GSTM1 null genotype as a risk factor associated with head and neck cancer are not conclusive and have shown conflicting results. A meta-analysis has been carried out on 22 case-control studies collected from the literature. Precision of the risk estimate and presence of publication bias in those studies are also evaluated by funnel plot analysis. RESULTS: A total of 3527 cases and 4211 controls constitute the subjects of meta-analysis. The principal outcome measured was the odds ratio (OR) for the risk of head and neck cancer. Pooling the studies together, the OR was 1.50 (95% confidence interval [CI], 1.21-1.87). When stratified according to Asians and Caucasians, the OR increased in the Asians (OR, 1.93; 95% CI, 1.29-2.90), suggesting that the risk is more pronounced in Asians. However, a substantial amount of publication bias is also associated with studies conducted on the Asian population. CONCLUSION: A review of the 22 case-control studies for risk of SCCHN and GSTM1 null genotype indicate that greater attention should be paid to designing future studies so that a more precise risk estimate can be achieved. (c) 2005 Wiley Periodicals, Inc.
Authors: G Cadoni; S Boccia; L Petrelli; P Di Giannantonio; D Arzani; A Giorgio; E De Feo; M Pandolfini; P Gallì; G Paludetti; G Ricciardi Journal: Acta Otorhinolaryngol Ital Date: 2012-02 Impact factor: 2.124
Authors: Leonor Varela-Lema; Emanuela Taioli; Alberto Ruano-Ravina; Juan M Barros-Dios; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Rajani A Bhisey; Gabriella Cadoni; Ettore Capoluongo; Chien-Jen Chen; William Foulkes; Eny Maria Goloni-Bertollo; Ana Hatagima; Richard B Hayes; Takahiko Katoh; Sergio Koifman; Phillip Lazarus; Johannes J Manni; Manoj Mahimkar; Shunji Morita; Jong Park; Kwang-Kyun Park; Erika Cristina Pavarino Bertelli; Enilze Maria de Souza Fonseca Ribeiro; Bidyut Roy; Margaret R Spitz; Richard C Strange; Qingyi Wei; Camille C Ragin Journal: Genet Med Date: 2008-06 Impact factor: 8.822
Authors: Sabrina S Santos; Rosalina J Koifman; Rafaela M Ferreira; Lilian F Diniz; Paul Brennan; Paolo Boffetta; Sergio Koifman Journal: Front Oncol Date: 2012-12-18 Impact factor: 6.244